ARCHIVES

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Group Chairman Balk At Board’s Recommendations

February 15, 1980

Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue

March 29, 2013

Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities

March 8, 1985

Cancer Letter Editor Wine Reporting Awards

June 11, 1999

FDA Recruiting ODAC Consumer Rep Candidates

March 31, 1995

Shubik Subcommittee Fails To Agree On Draft Document

February 13, 1976